BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/5/2017 12:48:28 AM | Browse: 535 | Download: 454
Publication Name World Journal of Gastroenterology
Manuscript ID 35427
Country/Territory China
2017-08-01 01:02
Peer-Review Started
2017-08-01 10:51
To Make the First Decision
2017-08-30 02:52
Return for Revision
2017-08-31 06:58
2017-09-13 09:53
Second Decision
2017-09-25 07:32
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2017-09-26 01:43
Articles in Press
2017-09-26 01:43
Publication Fee Transferred
2017-10-09 09:14
Edit the Manuscript by Language Editor
2017-10-18 19:46
Typeset the Manuscript
2017-10-31 03:50
Publish the Manuscript Online
2017-11-05 00:48
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Case Report
Article Title Extraordinary response of metastatic pancreatic cancer to apatinib after failed chemotherapy: A case report and literature review
Manuscript Source Unsolicited Manuscript
All Author List Cheng-Ming Li, Zhi-Chao Liu, You-Ting Bao, Xin-Dong Sun and Lin-Lin Wang
Author(s) ORCID Number
Cheng-Ming Li http://orcid.org/0000-0002-1111-3268
Zhi-Chao Liu http://orcid.org/0000-0001-7313-2504
You-Ting Bao http://orcid.org/0000-0001-6349-5125
Xin-Dong Sun http://orcid.org/0000-0003-2325-1366
Lin-Lin Wang http://orcid.org/0000-0002-2873-4204
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China 81402299
Project of Postdoctoral Innovation of Shandong Province 201501010
Project of Postdoctoral Science Foundation of China 2016M590640
Corresponding Author Lin-Lin Wang, MD, PhD, Chief Doctor, Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Science, No. 440, Jiyan Road, Jinan 250117, Shandong Province, China. 13793187739@163.com
Key Words Anti-angiogenesis; Apatinib; Pancreatic cancer; Targeted therapy; Vascular endothelial growth factor receptor-2
Core Tip As chemotherapy has limited efficacy in the treatment of advanced and metastatic pancreatic cancer, targeted therapy is becoming increasingly important in patients with pancreatic cancer. The case reported herein suggests that apatinib, a novel and highly selective tyrosine kinase inhibitor of vascular endothelial growth factor receptor-2, may be a promising and useful agent in the treatment of pancreatic cancer.
Publish Date 2017-11-05 00:48
Citation Li CM, Liu ZC, Bao YT, Sun XD, Wang LL. Extraordinary response of metastatic pancreatic cancer to apatinib after failed chemotherapy: A case report and literature review. World J Gastroenterol 2017; 23(41): 7478-7488
Url http://www.wjgnet.com/1007-9327/full/v23/i41/7478.htm
DOI http://dx.doi.org/10.3748/wjg.v23.i41.7478
Full Article (PDF) WJG-23-7478.pdf
Full Article (Word) WJG-23-7478.doc
Manuscript File 35427-Review.doc
Answering Reviewers 35427-Answering reviewers.pdf
Audio Core Tip 35427-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 35427-Conflict-of-interest statement.pdf
Copyright License Agreement 35427-Copyright assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 35427-Grant application form(s).pdf
Signed Informed Consent Form(s) or Document(s) 35427-Informed consent statement.pdf
Institutional Review Board Approval Form or Document 35427-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate 35427-Language certificate.pdf
Peer-review Report 35427-Peer-review(s).pdf
Scientific Misconduct Check 35427-Scientific misconduct check.pdf
Scientific Editor Work List 35427-Scientific editor work list.pdf